课题基金 / 基金详情

Molecular mechanisms of insulin resistance in obesity-induced IRS-1 heterozygous knockout mice.

Molecular mechanisms of insulin resistance in obesity-induced IRS-1 heterozygous knockout mice.
肥胖诱导的 IRS-1 杂合基因敲除小鼠胰岛素抵抗的分子机制。
批准号:
12671117
负责人:
ARAKI Eiichi
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001

项目摘要

项目成果

ARAKI Eiichi的其他基金

相似基金

相关文献

中文摘要
翻译
IRS-1是胰岛素受体的主要底物之一。IRS-1基因多态性已在2型糖尿病患者中以杂合方式被发现,并且一些突变的IRS-1在体外表现出胰岛素信号受损。然而,目前尚不清楚IRS-1多态性如何促进人类2型糖尿病的发展,因为杂合子IRS-1敲除(IRS-1 +/-)小鼠未显示异常。在这项研究中,我们通过给药金硫葡萄糖(GTG)制造肥胖的IRS-1 +/-小鼠,研究IRS-1表达降低对肥胖相关胰岛素抵抗的影响。在IRS-1 +/-小鼠以及野生型(WT)小鼠中给予GTG,与注射盐水的对照组相比,体重增加了约30%。肥胖的IRS-1+/-和肥胖的WT均显示空腹胰岛素水平高于瘦对照组,空腹血糖无显著差异。肥胖者IRS-1+/-胰岛素水平比肥胖者WT高1.5倍(p<0.05)。在葡萄糖负荷下,肥胖组的血糖水平明显高于瘦对照组,肥胖IRS-1 +/-组的血糖水平明显高于肥胖WT组。肥胖的IRS-1 +/-与肥胖的WT相比,表现出严重的胰岛素抵抗。肥胖的IRS-1 +/-小鼠的胰岛大小约为肥胖WT的1.4倍。与肥胖的WT相比,肥胖的IRS-1 +/-显示肝脏胰岛素受体和肌肉IRS-1的表达减少,这可以部分解释肥胖的IRS-1 +/-存在严重的胰岛素抵抗。这些结果支持了IRS- 1基因是2型糖尿病的可疑基因的观点,其在人类中的多态性可能会在肥胖等其他因素存在的情况下加重胰岛素抵抗。
英文摘要
IRS-1 is one of the major substrates for insulin receptor. IRS-1 gene polymorphisms have been identified m type 2 diabetes patients in a heterozygous manner, and some mutant IRS-1 show impaired insulin signal in vitro. However, it is unclear how the IRS-1 polymorphisms contribute to the development of type 2 diabetes in human, since the heterozygous IRS-1 knockout (IRS-1 +/-) mice showed no abnormality. In this study, we created obese IRS-1 +/- mice by administration of gold-thioglucose (GTG) and studied the impact of reduced IRS-1 expression in obesity-linked insulin resistance. GTG administration in IRS-1 +/- mice as well as in wild type (WT) mice, acieved 〜30 % body weight gain from their saline-injected controls. Both obese IRS-1+/- and obese WT revealed elevated fasting insulin levels compared to their lean controls with no significant difference in fasting glucose. The insulin level in obese IRS-1+/- was 1.5-fold higher than that in obese WT (p<0.05). The blood glucose levels upon glucose load were significantly elevated in obese groups when compared with their lean controls, and which were significantly higher in obese IRS-1 +/- than in obese WT. In insulin tolerance test, obese IRS-1 +/- revealed profound insulin resistance compared to obese WT. The size in islets of obese IRS-1 +/- mice were about 1.4-fold larger than that in obese WT. Obese IRS-1 +/- showed a decrease in expression of insulin receptor in the liver and IRS-1 in the muscle compared from obese WT mice, which could in part explain profound insulin resistance in obese IRS-1 +/-. These results support the idea that IRS- 1 gene is the suspectable gene for type 2 diabetes and its polymorphisms in human could worsen insulin resistance in the presence of additional factors, such as obesity.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
A.Shirakami, et al.: "Obese IRS-1 hetero knockout(IRS-1(+/-)) mice are insulin resistant compared to obese wild type(IRS-1(+/-)) mice"Diabetes mellitus ; Recent Advances for the 21^<st> Century (Elsevier Science). 411-414 (2000)
A.Shirakami 等人:“与肥胖野生型 (IRS-1(/-)) 小鼠相比,肥胖 IRS-1 异源基因敲除 (IRS-1(/-)) 小鼠具有胰岛素抵抗性”糖尿病;
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.Shirakami, et al.: "Obese IRS-1 hetero knockout (IRS-1 (+/-)) mice are insulin resistant compared to obese wild type (IRS-1 (+/+)) mice."Diabetes Mellitus ; Recent Advances for the 21st Century (Elsevier Science). 411-414 (2000)
A.Shirakami 等人:“与肥胖野生型 (IRS-1 (/)) 小鼠相比,肥胖 IRS-1 异源基因敲除 (IRS-1 ( /-)) 小鼠具有胰岛素抵抗性。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E. Araki, C.R. Kahn, and M. Shichiri: "Animal Models of IRS-1/IRS-2 Knockouts"Frontiers in Animal Diabetes Research vol.3. A.F. Sima and E Shafrir eds (Taylor & Francis). 361-374 (2002)
E. Araki、C.R. Kahn 和 M. Shichiri:“IRS-1/IRS-2 基因敲除的动物模型”动物糖尿病研究前沿第 3 卷。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Araki, et al.: "Animal models of IRS-1/IRS-2 knockouts."Frontiers in Animal Diabetes Research (Vol 3)(Harwood Academic Press). (2000)
E.Araki 等人:“IRS-1/IRS-2 基因敲除的动物模型。”动物糖尿病研究前沿(第 3 卷)(哈伍德学术出版社)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Molecular analysis of cell stress regulation by molecular chaperon and application for diabetes treatment
    • 批准号:
      23390243
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $6.24万
    • 财政年份:
      2011
    • 负责人:
      ARAKI Eiichi
    • 依托单位:
    Development of novel treatment for type 2 diabetes by regulating cellular stresses targeted to molecular chaperone.
    • 批准号:
      20390259
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2008
    • 负责人:
      ARAKI Eiichi
    • 依托单位:
    Analysis of the mechanisms of pancreatic β-cells destruction by intra-cellular oxidative stress and endoplasmic reticulum stress, and its application for the diabetes treatment.
    • 批准号:
      16390266
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.15万
    • 财政年份:
      2004
    • 负责人:
      ARAKI Eiichi
    • 依托单位:
    New pathogenesis of diabetes mellitus : Role of endoplasmic reticulum stress mediated apoptosis on pancreatic β-cells
    • 批准号:
      14370339
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      2002
    • 负责人:
      ARAKI Eiichi
    • 依托单位:
    国内基金
    海外基金
    西方饮食通过“肠道菌群-Rspo1”轴促进肥胖与肠道吸收的机制研究
    • 批准号:
      82370845
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      洪洁
    • 依托单位:
    SUCLA2失调控介导的琥珀酸代谢异常促进巨噬细胞炎性活化及肥胖发生
    • 批准号:
      32000525
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2020
    • 负责人:
      蒋昊文
    • 依托单位:
    肥大细胞与脂肪细胞互作调控长期高脂饮食小鼠附睾脂肪组织萎缩重构的机制
    • 批准号:
      32070757
    • 项目类别:
      面上项目
    • 资助金额:
      58.0万元
    • 批准年份:
      2020
    • 负责人:
      刘健
    • 依托单位:
    SerRS在三阴性乳腺癌脂代谢失调中的作用机制及靶向干预
    • 批准号:
      32070752
    • 项目类别:
      面上项目
    • 资助金额:
      59.0万元
    • 批准年份:
      2020
    • 负责人:
      史毅
    • 依托单位: